Cleared Traditional

K231166 - Levina, Levina Incontinence Stimulation Electrodes (Sterile), Pelvic Floor Muscle Probe Electrodes (FDA 510(k) Clearance)

Jan 2024
Decision
268d
Days
Class 2
Risk

K231166 is an FDA 510(k) clearance for the Levina, Levina Incontinence Stimulation Electrodes (Sterile), Pelvic Floor Muscle Probe Electrodes. This device is classified as a Stimulator, Electrical, Non-implantable, For Incontinence (Class II - Special Controls, product code KPI).

Submitted by Zmi Electronics , Ltd. (Kaohsiung, TW). The FDA issued a Cleared decision on January 18, 2024, 268 days after receiving the submission on April 25, 2023.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5320.

Submission Details

510(k) Number K231166 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 2023
Decision Date January 18, 2024
Days to Decision 268 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code KPI - Stimulator, Electrical, Non-implantable, For Incontinence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5320

Similar Devices - KPI Stimulator, Electrical, Non-implantable, For Incontinence

Well-Life Incontinence Stimulation System (WL-2405i(P))
K251760 · Well-Life Healthcare , Ltd. · Feb 2026
BTL-398
K241516 · BTL Industries, Inc. · Feb 2025
Well-Life Probe Electrode for Stimulation/EMG Probe (Model: SA), Well-Life Incontinence Stimulation/EMG Electrode Probe, Well-Life Probe Electrode
K222528 · Well-Life Healthcare Limited · Dec 2022
Everyway Incontinence Stimulation System
K213116 · Everyway Medical Instruments Co.,Ltd · Dec 2021
MyOnyx System
K201014 · Thought Technology , Ltd. · Jan 2021